Tell us about your background. I am Paul Bravetti, a passionate executive with a strong focus on scientific innovation and entrepreneurial ventures. My background combines a Doctor of Pharmacy degree with an MBA in business management from HEC Paris. I

Teitur means happiness in Old Norse. What inspired you to choose this name for the company, and how does it reflect your vision for developing treatments for neurodegenerative diseases? At Teitur, our name captures the essence of our mission. Meaning

Tell us about your background. I am an organic chemist who has worked in many different fields within pharma and biotech. I have worked at Novo Nordisk, H. Lundbeck and at a Danish CRO working in different areas and roles

Tell us more about your background. Throughout my career, I have focused and been involved in creating, driving and transacting on innovation in medicine. I have led innovation and drug discovery with different technologies including RNA therapeutics, genetic medicines, drug

Tell us about your background. My background is in computational biology and bioinformatics, which I studied at ETH Zürich. I then went on to combine my fascination for cancer research and my data analysis skills and joined the research group

Tell us about your background. My career began with a PhD in molecular biology and microbiology, fueling a lifelong fascination with the complexities of biological systems. This path led me to a pivotal role in synthetic biology at MIT, where

What is your background? I hold a PharmD and a dual degree from EM Lyon Business School, with a major in Entrepreneurship. What/who inspired you to go into the life sciences? Has there been someone instrumental throughout your journey? I

Can you tell us more about Oncobit and the reasons you decided to found it? Two of my co-founders are professors at the University and University Hospital of Zurich and experienced first-hand the limitations linked to cancer monitoring. So Oncobit